Insulin resistance ups T2D risk, independent of BMI
Robert A. Scott, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined the correlations of genetic scores with euglycemic-hyperinsulinemic clamp- and oral glucose tolerance test-based measures of insulin resistance and secretion in up to 18,565 individuals. They also examined the correlation between genetic variants and T2D risk among 8,124 normal-weight, overweight, and obese incident T2D cases.
The researchers found that the insulin resistance score correlated with lower insulin sensitivity, as measured by M/I value (P = 0.004). Significant correlations were seen for the insulin resistance score with lower BMI and gluteofemoral fat-mass, and with higher alanine transaminase and gamma-glutamyltransferase. In leaner individuals, the secretion score was more strongly associated with T2D (Pinteraction = 0.001), but the association between insulin resistance score and T2D did not differ among BMI- or waist-strata (Pinteraction > 0.31).
"While insulin resistance is often considered secondary to obesity, the association of the insulin resistance score with lower BMI and adiposity and with incident T2D even among individuals of normal weight highlights the role of insulin resistance and ectopic fat distribution in T2D, independently of body size," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Full Text (subscription or payment may be required)
Copyright © 2014 HealthDay. All rights reserved.